SCHEMBL8869871

SCHEMBL8869871

COCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(CCNC(=O)Cc3ccccc3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 5/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA5A P35218 1/20 0.48
CA7 P43166 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.46
HIF1A Q16665 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
PPARA Q07869 1/20 0.43
ALDH1A1 P00352 2/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869090 0.93 ALDH1A1 (0.51) P4HTMSMN1; SMN2HIF1ANPC1RAB9A
SCHEMBL8869248 0.92 P4HTM (0.47) P4HTMCA1CA2CA5ACA7
SCHEMBL8869814 0.91 P4HTM (0.48) P4HTMCA1CA2CA5ACA7
SCHEMBL8868425 0.91 P4HTM (0.53) P4HTMSMN1; SMN2HIF1ANPC1RAB9A
SCHEMBL8869732 0.91 P4HTM (0.53) P4HTMCA1CA2CA5ACA7
SCHEMBL8867758 0.91 P4HTM (0.46) P4HTMCA1CA2CA5ACA7
SCHEMBL8868789 0.90 P4HTM (0.48) P4HTMCA1CA2CA5ACA7
SCHEMBL9144421 0.90 P4HTM (0.52) P4HTMCA1CA2CA5ACA7
SCHEMBL8869118 0.90 PTPN1 (0.51) P4HTMSMN1; SMN2PPARAALDH1A1LMNA
SCHEMBL8868481 0.89 HDAC3 (0.51) P4HTMCA1CA2CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed